August 26, 2014
Wellesley, Mass., Aug 26, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets, the global market for G-protein coupled receptors (GPCR) or GPCR-targeting drugs fell sharply during the last three years due to expiration of blockbuster products. The market dropped from $111 billion to almost $100 billion between 2010 and 2013 with a -3.4% compound annual growth rate (CAGR). It is, however, forecast to increase its sales revenue from approximately $1 billion in 2013 to $114 billion by 2018, with a CAGR of 2.7%.
The introduction of novel pharmaceuticals is contributing to the forecasted growth of the global market for the GPCR-targeting drugs, along with the fast growing classes of drugs that were initiated in the last several years. The U.S. market is projected to witness highest growth during the next five years, but the countries of Brazil, Russia, India and China and the rest of the world are anticipated to experience the maximum CAGR of 5.4% and 6.3% respectively.
“The recent technological advances and accumulating structural and functional literature on the physiological and pharmacological features of the GPCRs have shown that these targets have versatile utilities in the treatment of a broad spectrum of diseases across almost every therapeutic area,” says BCC Research analyst Ufuk Ezer. “New findings and novel technologies in target-lead discovery and the lengthening list of druggable targets are the central motivation for the investments in the GPCR drug research and development.”
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets elaborates on the present landscape for major segments of the GPCR drug market for the time period 2013 through 2018.The key drivers and limiting factors as well as major threats versus opportunities for the future growth and direction of the market are identified and addressed within this report.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets( BIO136A )
Publish Date: Aug 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.